AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1,015.6 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis

Jiange Qiua,1Qing Xub,1Tahira PanahaA K M Helal MorshedaXue WangaFengmei ZhouaWenjing LiucJufeng WangcYe ZhangcBingjie Liua( )Bing-Hua Jianga( )
The First Affiliated Hospital of Zhengzhou University, The Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan 450000, China
Department of Pathology, Nanjing Medical University, Nanjing, Jiangsu 210029, China
The Affiliated Cancer Hospital of Zhengzhou University, Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan 450000, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

References

1

Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022;21(1):114.

2

Fichman Y, Rowland L, Oliver MJ, Mittler R. ROS are evolutionary conserved cell-to-cell stress signals. Proc Natl Acad Sci U S A. 2023;120(31):e2305496120.

3

Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22(5):280-297.

4

Kim YM, Kim SJ, Tatsunami R, Yamamura H, Fukai T, Ushio-Fukai M. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am J Physiol Cell Physiol. 2017;312(6):C749-C764.

Genes & Diseases
Article number: 101378
Cite this article:
Qiu J, Xu Q, Panah T, et al. Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis. Genes & Diseases, 2025, 12(2): 101378. https://doi.org/10.1016/j.gendis.2024.101378

79

Views

2

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics

Received: 23 November 2023
Published: 17 July 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Return